171 related articles for article (PubMed ID: 33658218)
1. Intrahepatic cholangiocarcinoma in a non-cirrhotic liver in a patient with homozygous ZZ alpha-1 antitrypsin deficiency.
Vuurberg NE; Van den Boom AL; Van den Heuvel MC; Klaase JM
BMJ Case Rep; 2021 Mar; 14(3):. PubMed ID: 33658218
[TBL] [Abstract][Full Text] [Related]
2. Clinical and histologic features of adults with alpha-1 antitrypsin deficiency in a non-cirrhotic cohort.
Clark VC; Marek G; Liu C; Collinsworth A; Shuster J; Kurtz T; Nolte J; Brantly M
J Hepatol; 2018 Dec; 69(6):1357-1364. PubMed ID: 30138687
[TBL] [Abstract][Full Text] [Related]
3. BRAF V600E mutation in biliary proliferations associated with α
Angkathunyakul N; Rosini F; Heaton N; Foskett P; Quaglia A
Histopathology; 2017 Feb; 70(3):485-491. PubMed ID: 27627051
[TBL] [Abstract][Full Text] [Related]
4. Is heterozygous alpha-1-antitrypsin deficiency type PIZ a risk factor for primary liver carcinoma?
Zhou H; Ortiz-Pallardó ME; Ko Y; Fischer HP
Cancer; 2000 Jun; 88(12):2668-76. PubMed ID: 10870048
[TBL] [Abstract][Full Text] [Related]
5. Cholangiocarcinoma in two siblings with emphysema and alpha-1-antitrypsin deficiency.
Parham DM; Paterson JR; Gunn A; Guthrie W
Q J Med; 1989 Apr; 71(264):359-67. PubMed ID: 2556731
[TBL] [Abstract][Full Text] [Related]
6. Quantitative Lipid Profiling Reveals Major Differences between Liver Organoids with Normal Pi*M and Deficient Pi*Z Variants of Alpha-1-antitrypsin.
Pérez-Luz S; Lalchandani J; Matamala N; Barrero MJ; Gil-Martín S; Saz SR; Varona S; Monzón S; Cuesta I; Justo I; Marcacuzco A; Hierro L; Garfia C; Gomez-Mariano G; Janciauskiene S; Martínez-Delgado B
Int J Mol Sci; 2023 Aug; 24(15):. PubMed ID: 37569847
[TBL] [Abstract][Full Text] [Related]
7. Liver disease in alpha-1 antitrypsin deficiency: current understanding and future therapy.
Teckman JH
COPD; 2013 Mar; 10 Suppl 1():35-43. PubMed ID: 23527737
[TBL] [Abstract][Full Text] [Related]
8. [Hepatic involvement in hereditary alpha-1-antitrypsin deficiency].
Lachaux A; Dumortier J
Rev Mal Respir; 2014 Apr; 31(4):357-64. PubMed ID: 24750955
[TBL] [Abstract][Full Text] [Related]
9. Hepatic-targeted RNA interference provides robust and persistent knockdown of alpha-1 antitrypsin levels in ZZ patients.
Turner AM; Stolk J; Bals R; Lickliter JD; Hamilton J; Christianson DR; Given BD; Burdon JG; Loomba R; Stoller JK; Teckman JH
J Hepatol; 2018 Aug; 69(2):378-384. PubMed ID: 29572094
[TBL] [Abstract][Full Text] [Related]
10. Liver Fibrosis and Metabolic Alterations in Adults With alpha-1-antitrypsin Deficiency Caused by the Pi*ZZ Mutation.
Hamesch K; Mandorfer M; Pereira VM; Moeller LS; Pons M; Dolman GE; Reichert MC; Schneider CV; Woditsch V; Voss J; Lindhauer C; Fromme M; Spivak I; Guldiken N; Zhou B; Arslanow A; Schaefer B; Zoller H; Aigner E; Reiberger T; Wetzel M; Siegmund B; Simões C; Gaspar R; Maia L; Costa D; Bento-Miranda M; van Helden J; Yagmur E; Bzdok D; Stolk J; Gleiber W; Knipel V; Windisch W; Mahadeva R; Bals R; Koczulla R; Barrecheguren M; Miravitlles M; Janciauskiene S; Stickel F; Lammert F; Liberal R; Genesca J; Griffiths WJ; Trauner M; Krag A; Trautwein C; Strnad P;
Gastroenterology; 2019 Sep; 157(3):705-719.e18. PubMed ID: 31121167
[TBL] [Abstract][Full Text] [Related]
11. Alpha-1 antitrypsin deficiency: A re-surfacing adult liver disorder.
Fromme M; Schneider CV; Trautwein C; Brunetti-Pierri N; Strnad P
J Hepatol; 2022 Apr; 76(4):946-958. PubMed ID: 34848258
[TBL] [Abstract][Full Text] [Related]
12. [Heterozygous alpha-1-antitrypsin deficiency (PiMZ): risk factor in the development of primary liver carcinoma in non-cirrhotic liver?].
Manekeller S; Sauerbruch T; Fischer HP; Propping P; Hirner A
Z Gastroenterol; 2010 Oct; 48(10):1211-4. PubMed ID: 20886426
[TBL] [Abstract][Full Text] [Related]
13. Alpha-1-antitrypsin phenotypes in adult liver disease patients.
Topic A; Alempijevic T; Milutinovic AS; Kovacevic N
Ups J Med Sci; 2009; 114(4):228-34. PubMed ID: 19961268
[TBL] [Abstract][Full Text] [Related]
14. Alpha-1-Antitrypsin Deficiency Liver Disease.
Patel D; Teckman JH
Clin Liver Dis; 2018 Nov; 22(4):643-655. PubMed ID: 30266154
[TBL] [Abstract][Full Text] [Related]
15. Outcomes for recipients of liver transplantation for alpha-1-antitrypsin deficiency–related cirrhosis.
Carey EJ; Iyer VN; Nelson DR; Nguyen JH; Krowka MJ
Liver Transpl; 2013 Dec; 19(12):1370-6. PubMed ID: 24019185
[TBL] [Abstract][Full Text] [Related]
16. Alpha 1-antitrypsin deficiency: memorandum from a WHO meeting.
Bull World Health Organ; 1997; 75(5):397-415. PubMed ID: 9447774
[TBL] [Abstract][Full Text] [Related]
17. Diagnosis of alpha-1-antitrypsin deficiency in bleeding disorder-related neonatal death.
Kats-Ugurlu G; Hogeveen M; Driessen A; van den Ouweland AM; Hulsbergen-van de Kaa C
Eur J Pediatr; 2011 Jan; 170(1):103-6. PubMed ID: 20811907
[TBL] [Abstract][Full Text] [Related]
18. Cirrhosis and hepatocellular carcinoma in a patient with heterozygous (MZ) alpha-1-antitrypsin deficiency.
Marwick TH; Cooney PT; Kerlin P
Pathology; 1985 Oct; 17(4):649-52. PubMed ID: 3005953
[TBL] [Abstract][Full Text] [Related]
19. Liver carcinoma in PiZ alpha-1-antitrypsin deficiency.
Zhou H; Fischer HP
Am J Surg Pathol; 1998 Jun; 22(6):742-8. PubMed ID: 9630182
[TBL] [Abstract][Full Text] [Related]
20. Liver organoids reproduce alpha-1 antitrypsin deficiency-related liver disease.
Gómez-Mariano G; Matamala N; Martínez S; Justo I; Marcacuzco A; Jimenez C; Monzón S; Cuesta I; Garfia C; Martínez MT; Huch M; Pérez de Castro I; Posada M; Janciauskiene S; Martínez-Delgado B
Hepatol Int; 2020 Jan; 14(1):127-137. PubMed ID: 31832977
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
